Thomas discusses the challenges of statin side effects in real-world scenarios, despite low reported rates in clinical trials. The struggle of convincing patients when side effects are perceived, even if not directly linked to statins, poses a significant obstacle in treatment adherence. The evolution from Mevacor to simvastatin marked a pivotal moment in showcasing the effectiveness of statins.
